Brian Crucian, Russell Valentine, Kimesha Calaway, Rachael Miller, Kathleen Rubins, Michael Hopkins, Zachary Salas, Stephanie Krieger, George Makedonas, Mayra Nelman-Gonzalez, Kathleen McMonigal, Gail Perusek, Kris Lehnhardt, Benjamin Easter
During long duration orbital space missions, astronauts experience immune system dysregulation, the persistent reactivation of latent herpesviruses, and some degree of clinical incidence. During planned NASA 'Artemis' deep space missions the stressors that cause this phenomenon will increase, while clinical care capability will likely be reduced. There is currently minimal clinical laboratory capability aboard the International Space Station (ISS). The ability to monitor the white blood cell count (WBC) and differential during spaceflight has been an unmet NASA medical requirement, primarily due to a lack of capable hardware...
November 2021: Life Sciences in Space Research